NEUE SUBSTITUIERTE 3-PHENOXY- UND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINE
申请人:Boehringer Ingelheim Pharma KG
公开号:EP1154983A1
公开(公告)日:2001-11-21
US6441237B1
申请人:——
公开号:US6441237B1
公开(公告)日:2002-08-27
[DE] NEUE SUBSTITUIERTE 3-PHENOXY- UND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINE<br/>[EN] NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES<br/>[FR] NOUVELLES 3-PHENOXY ET 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES SUBSTITUEES
申请人:BOEHRINGER INGELHEIM PHARMA
公开号:WO2000048987A1
公开(公告)日:2000-08-24
Die vorliegende Patentanmeldung betrifft neue substituierte 3-Phenoxy- bzw. 3-Phenylalkyloxy-2-phenyl-propylamine der allgemeinen Formel (1), Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
2-Amino-2-oxazolines, V: Synthesis of Some 5-Dialkylaminomethyl-2-amino-2-oxazolines and Evaluation of Their Diuretic Activity
5‐dialkylaminomethyl‐2‐amino‐2‐oxazolines was prepared and screened for diuretic activity. These compounds were previously examined for their lipophilic behaviour using a reversed‐phase HPLC technique. The capacity factors, expressed as log k'w, were correlated with the partition coefficient log P. A QSAR analysis of the diuretic activity in relation with the lipophilicity was attempted for these structurally
制备了一系列 5-二烷基氨基甲基-2-氨基-2-恶唑啉并筛选了利尿活性。之前使用反相 HPLC 技术检查了这些化合物的亲脂行为。以log k'w 表示的容量因子与分配系数log P 相关。针对这些结构相关的化合物尝试对与亲脂性相关的利尿活性进行QSAR 分析。